Soleno Therapeutics Inc (SLNO) SEC Filings — 2024

Filings

• Soleno Therapeutics Enters Material Definitive Agreement — 8-K · Dec 17, 2024
• Soleno Therapeutics Files 8-K — 8-K · Nov 26, 2024
• Perceptive Advisors Amends Soleno Therapeutics Stake — SC 13D/A · Nov 19, 2024
• Soleno Therapeutics Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Perceptive Advisors Adjusts Soleno Therapeutics Stake — SC 13D/A · Nov 14, 2024
• Soleno Therapeutics Inc SC 13G Filing — SC 13G · Nov 14, 2024
• Soleno Therapeutics Inc SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Soleno Therapeutics Files 8-K on Financials — 8-K · Nov 6, 2024
• Solen Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
• Soleno Therapeutics Inc SC 13G Filing — SC 13G · Oct 24, 2024
• Carlyle Group Adjusts Stake in Soleno Therapeutics — SC 13D/A · Oct 21, 2024
• Carlyle Group Files SC 13D/A Amendment for Soleno Therapeutics — SC 13D/A · Oct 15, 2024
• Carlyle Group Adjusts Soleno Therapeutics Stake — SC 13D/A · Oct 10, 2024
• Soleno Therapeutics Inc SC 13G Filing — SC 13G · Oct 3, 2024
• Carlyle Group Files 13D Amendment for Soleno Therapeutics — SC 13D/A · Sep 10, 2024
• Soleno Therapeutics Inc SC 13G Filing — SC 13G · Sep 5, 2024
• Soleno Therapeutics Appoints New Chief Medical Officer — 8-K · Aug 15, 2024
• Soleno Therapeutics Files 8-K on Operations — 8-K · Aug 7, 2024
• Solen Therapeutics Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 7, 2024
• Solen Therapeutics Adds Directors, Adjusts Executive Pay — 8-K · Jul 19, 2024
• Soleno Therapeutics Closes $100M Public Offering — 8-K · Jun 28, 2024
• Soleno Therapeutics Secures $50M Credit Facility — 8-K · Jun 20, 2024
• Soleno Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jun 6, 2024
• Soleno Therapeutics Files 8-K on Financials — 8-K · May 10, 2024
• Soleno Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Soleno Therapeutics Files 8-K: Material Agreement & Other Events — 8-K · May 7, 2024
• Vivo Opportunity Fund Ups Soleno Stake to 10.8% — SC 13D/A · May 1, 2024
• Soleno Therapeutics Merges with Altacell, Renamed ATCL — 8-K · Apr 29, 2024
• Soleno Therapeutics Appoints New CMO and CSO, CMO Departs — 8-K · Apr 22, 2024
• Soleno Therapeutics Files 8-K on Financials — 8-K · Mar 7, 2024
• SolenO Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
• Soleno Therapeutics Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Soleno Therapeutics Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Soleno Therapeutics Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Adage Capital Partners Amends Soleno Therapeutics Stake — SC 13G/A · Feb 7, 2024
• SOLENO THERAPEUTICS 8-K: Leadership & Compensation Changes Reported — 8-K · Jan 30, 2024
• SOLENO THERAPEUTICS Reports Executive Changes & Compensation on Jan 4 — 8-K · Jan 5, 2024